Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-24-046239
Filing Date
2024-11-12
Accepted
2024-11-12 17:25:20
Documents
5
Effectiveness Date
2024-11-12

Document Format Files

Seq Description Document Type Size
1 S-8 ny20037443x2_s8.htm S-8 51021
2 EXHIBIT 5.1 ny20037443x2_ex5-1.htm EX-5.1 8625
3 EXHIBIT 23.1 ny20037443x2_ex23-1.htm EX-23.1 2818
4 FILING FEES TABLE ny20037443x2_ex107.htm EX-FILING FEES 16802
5 ny20037443x2_cooley.jpg GRAPHIC 2768
  Complete submission text file 0001140361-24-046239.txt   84343
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283180 | Film No.: 241450023
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)